Processa Pharmaceuticals Inc banner

Processa Pharmaceuticals Inc
NASDAQ:PCSA

Watchlist Manager
Processa Pharmaceuticals Inc Logo
Processa Pharmaceuticals Inc
NASDAQ:PCSA
Watchlist
Price: 3.18 USD 7.43%
Market Cap: $8.5m

During the last 3 months Processa Pharmaceuticals Inc insiders bought 43k USD , and have not sold any shares. The stock price has dropped by 2% over this period (open performance analysis).

The last transaction was made on Mar 31, 2026 by Neal James R , who bought 2k USD worth of PCSA shares.

Last Transactions:
Neal James R
$+2k
Skibsted Russell
$+5.9k
Young David
$+4.6k
Baluch Khoso
$+5.8k
Bigora Sian
$+5.3k
Guy Wendy
$+4.7k
Lin Patrick
$+4.1k
Ng George K
$+5.4k
Pannu Geraldine
$+5.3k
Ng George K
$+2.8k
Yorke Justin W
$+395.6
Lin Patrick
$+1.4k
Young David
$+4k
Young David
$+51.5k
Young David
$+50.5k
Lin Patrick
$+3.6k
Lin Patrick
$+5.9k
Ng George K
$+27k
Yorke Justin W
$+21.5k
Young David
$+1.6k
Young David
$+549.9
Young David
$+480
Young David
$+450
Young David
$+520
Lin Patrick
$+159.5
Lin Patrick
$+141.8
Lin Patrick
$+187.6
Yorke Justin W
$-306.9
Lin Patrick
$+600
Lin Patrick
$+600
Yorke Justin W
$-989.2
Yorke Justin W
$-1.3k
View All Transactions

During the last 3 months Processa Pharmaceuticals Inc insiders bought 43k USD , and have not sold any shares. The stock price has dropped by 2% over this period (open performance analysis).

The last transaction was made on Mar 31, 2026 by Neal James R , who bought 2k USD worth of PCSA shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
9
43k USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Processa Pharmaceuticals Inc
Insider Trading Chart

Processa Pharmaceuticals Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Processa Pharmaceuticals Inc
Last Insider Transactions

Global
Insiders Monitor

Processa Pharmaceuticals Inc
Glance View

Market Cap
8.5m USD
Industry
Pharmaceuticals

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. The company is headquartered in Hanover Maryland, Maryland and currently employs 15 full-time employees. The company went IPO on 2013-10-07. The company is focused on development of drug products that are intended to provide treatment for patients who have unmet medical need condition that effects survival or the patient’s life and no treatment options. The company has five drugs: four in various stages of clinical development (PCS499, PCS12852, PCS3117 and PCS6422) and one in nonclinical development (PCS11T). PCS499 is an oral tablet that is a deuterated analog of one of the major metabolites of pentoxifylline (PTX ). PCS12852 is a highly specific and potent 5-hydroxytryptamine 4 (5-HT4) receptor agonist. is a novel, investigational, oral small molecule nucleoside compound. PCS3117 is an analog of the endogenous nucleoside, cytidine, and an analog of the cancer drug gemcitabine. PCS6422 is an oral, potent, selective and irreversible inhibitor of dihydropyrimidine dehydrogenase (DPD). PCS11T is being developed for the treatment of the solid tumor.

PCSA Intrinsic Value
2.51 USD
Overvaluation 21%
Intrinsic Value
Price $3.18

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett